Star Laboratories

What Star Laboratories does

Star Laboratories is a Pakistan-based pharmaceutical manufacturer founded in 1960 in Lahore by Muhammad Iqbal Malik and now operated under family ownership across three generations of the Malik family. The company manufactures generic medicines across two business units: human healthcare (antibiotics, anti-malarials, vitamins, anti-inflammatory, CNS, GI, and dermatology products) and veterinary healthcare (antibiotics, anti-parasitics, reproductive hormones, vitamins, and nutritionals for livestock, poultry, and pets). The portfolio exceeds 500 SKUs spanning injectables, oral solids, oral liquids, topicals, semi-solids, and aerosols, manufactured at a single integrated facility on Multan Road in Lahore.

The company operates a B2B enterprise field sales model, selling through international distributors across 30+ countries spanning the Middle East and North Africa, Sub-Saharan Africa, South Asia, Central Asia, and Southeast Asia, alongside domestic Pakistani sales. Manufacturing infrastructure uses modular production systems with automation and real-time data analytics, certified to ISO 9001:2015 (since 2018), ISO 14001:2015, and ISO 45001:2018. A dedicated R&D division established in 1999 supports formulation development, with stated but unsubstantiated use of genomics, biotechnology, and artificial intelligence in drug discovery. Pricing is quote-based for bulk orders, consistent with traditional generic pharmaceutical distribution norms, and no revenue, headcount, or financial details are publicly disclosed.

The go-to-market relies on distributor relationships, international trade exhibitions (Angola FILDA, Kenya Aviana Vet, Philippines Livestock Expo), customer delegation exchanges, and PR-driven earned media rather than digital channels. The company has been recognized with consecutive PESA Export Awards from PPMA as Pakistan's top pharmaceutical exporter in 2023 and 2024. Star Laboratories remains a privately held company with no institutional funding rounds, no acquisition activity, and no parent company, distinguishing it from publicly listed Pakistani pharma peers and positioning it as a founder-led, export-driven mid-tier generic manufacturer.

Name

Star Laboratories

Legal name

Star Laboratories Pvt Ltd.

Website

https://starlabs.com.pk

Company type

Private

Founded year

1960

Operating status

Operating

Short description

Star Laboratories is a Lahore-based pharmaceutical manufacturer producing 500+ generic medicines for human and veterinary healthcare, exporting to 30+ countries across MENA, Sub-Saharan Africa, Central Asia, South Asia, and Southeast Asia through B2B distributor networks.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic & Private-Label Veterinary Pharmaceuticals (HLAMAEAM)

akta.pro secondary industries

Antimicrobials & Anti-infectives (HLAMAEAE), Parasiticides & Ectoparasite Control (Flea/Tick/Heartworm) (HLAMAEAD), Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Pharmaceutical manufacturing
• Veterinary medicines
• Human generic drugs
• Antibiotic formulations
• Pharmaceutical exports

Headquarters

HQ city

Lahore

HQ country

Pakistan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Manufacturing and selling pharmaceutical products for both human and veterinary healthcare. Revenue generated through domestic sales and international exports of medications including injectables, oral solids, liquid dosage forms, and topical treatments.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Star Laboratories manufactures and sells a portfolio of 500+ generic pharmaceutical formulations for human and veterinary healthcare, including oral solids (tablets, capsules, suspensions), injectables, oral liquids, topical treatments, boluses, powders, drenches, and aerosol sprays. The company produces antibiotics (penicillins, cephalosporins, fluoroquinolones, macrolides), anthelmintics, anti-inflammatories, anti-malarials, vitamins and supplements, and gastrointestinal medications, selling to distributors, hospitals, pharmacies, veterinarians, doctors, and agricultural businesses across 30+ countries.

Product overview

Star Laboratories is a pharmaceutical company with over 60 years of experience, offering a diverse portfolio of more than 500 pharmaceutical products for both human and animal healthcare. The company operates in two main divisions: Human Pharmaceuticals and Veterinary Medicines. Human products include oral solids (tablets, capsules, suspensions), injectable/parenteral formulations, oral liquids, and topical products. Veterinary products span injectables, liquid dosage forms, solid dosage forms (boluses, powders), semi-solid preparations, and aerosol/spray formulations. The portfolio includes antibiotics (penicillins, cephalosporins, fluoroquinolones, macrolides), anthelmintics (albendazole, levamisole, ivermectin), anti-inflammatories, vitamins and supplements, anti-malarials, and gastrointestinal medications. The company serves global markets across Middle East, Africa, South Asia, Central Asia, and Southeast Asia, exporting to over 30 countries.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Products trusted in over 30 countries globally
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators5 records

Recent moves10 records

Expansion highlights5 records

Direct peers

• Getz Pharma: Pakistan-based pharmaceutical manufacturer producing generic and branded formulations across human therapeutic areas. Directly comparable as a fellow top-tier Pakistani pharma exporter with similar international ambitions and product breadth.
• Ferozsons Laboratories: Pakistani pharma company with diversified portfolio including human generics and healthcare products. Comparable scale and export orientation, listed on the Pakistan Stock Exchange providing market reference for valuation.
• Hilton Pharma: Pakistani pharmaceutical manufacturer producing a broad range of branded generics for human health. Closely comparable in terms of product mix (antibiotics, anti-malarials, NSAIDs) and domestic plus export orientation.
• Nabiqasim Industries: Pakistan-based pharmaceutical manufacturer offering infusions, injectables, and oral formulations across therapeutic categories. Directly comparable in dosage-form breadth and B2B pharma distribution model.
• AGP Limited: Pakistani pharmaceutical manufacturer with significant export presence across multiple continents. Comparable in scale, manufacturing capabilities, and emerging-market export footprint similar to Star Labs.
• Bosch Pharmaceuticals: Pakistani pharmaceutical company focused on branded generics with international distribution. Comparable in product portfolio and export-driven business model serving emerging markets.
• Searle Pakistan: Pakistani pharma manufacturer with broad branded-generic portfolio including human and consumer health products. Comparable in scale, manufacturing maturity, and therapeutic area coverage.

Broad incumbents

• Aurobindo Pharma: India-based global generic pharmaceutical manufacturer with extensive API and finished dosage portfolio across 150+ countries. Comparable as a much larger established exporter in many of the same therapeutic categories and emerging markets where Star Labs competes.
• Cipla: One of India's largest pharmaceutical companies with strong presence in Africa, South Asia, and emerging markets, including notable leadership in anti-malarials and respiratory products. Directly competes in Star Labs' core therapeutic and geographic segments.

Regional players

• Aspen Pharmacare: South Africa-headquartered global specialty and generics pharmaceutical company with strong African distribution footprint. Comparable as a large-scale emerging-market pharma manufacturer targeting similar institutional buyer segments across Sub-Saharan Africa.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Star Laboratories